AT THE MARKET OFFERING AGREEMENT
Exhibit
1.1
April
30, 2019
Xxxx
Capital Partners, LLC
000 Xxx
Xxxxxxxx Xxxxx
Xxxxxxx
Xxxxx, Xxxxxxxxxx 00000
Ladies
and Gentlemen:
New Age Beverages Corporation, a Washington
corporation (the “Company”), confirms its
agreement (this “Agreement”) with Xxxx
Capital Partners, LLC (the “Manager”) as
follows:
1. Definitions. The terms that
follow, when used in this Agreement and any Terms Agreement, shall
have the meanings indicated.
“Accountants” shall have
the meaning ascribed to such term in Section 3(o).
“Act” shall mean the
Securities Act of 1933, as amended, and the rules and regulations
of the Commission promulgated thereunder.
“Action” shall have the
meaning ascribed to such term in Section 3(q).
“Affiliate” shall mean any
Person that, directly or indirectly, through one or more
intermediaries, controls or is controlled by, or is under common
control with, a Person, as such terms are used in and construed
under Rule 144 of the Act.
“Applicable Time” shall
mean, with respect to any Shares, the time of sale of such Shares
pursuant to this Agreement or any relevant Terms
Agreement.
“Base Prospectus” shall
mean the base prospectus contained in the Registration Statement at
the Execution Time.
“Board” shall have the
meaning ascribed to such term in Section 2(b)(iii).
“Broker Fee” shall have
the meaning ascribed to such term in Section 2(b)(v).
“Business Day” shall mean
any day other than a Saturday, a Sunday or a legal holiday or a day
on which banking institutions or trust companies are authorized or
obligated by law to close in New York City.
“Commission” shall mean
the United States Securities and Exchange Commission.
“Common Stock” shall have
the meaning ascribed to such term in Section 2.
“Common Stock Equivalents”
shall have the meaning ascribed to such term in Section
3(g).
“Company Counsel” shall
have the meaning ascribed to such term in Section
4(l).
“DTC” shall have the
meaning ascribed to such term in Section 2(b)(vii).
“Effective Date” shall
mean each date and time that the Registration Statement and any
post-effective amendment or amendments thereto became or becomes
effective.
“Evaluation Date” shall
have the meaning ascribed to such term in Section
3(y).
“Exchange Act” shall mean
the Securities Exchange Act of 1934, as amended, and the rules and
regulations of the Commission promulgated thereunder.
“Execution Time” shall
mean the date and time that this Agreement is executed and
delivered by the parties hereto.
“Filing Date” shall have
the meaning ascribed to such term in Section 4(w).
“FINRA” shall have the
meaning ascribed to such term in Section 3(e).
“GAAP” shall have the
meaning ascribed to such term in Section 3(n).
“Incorporated Documents”
shall mean the documents or portions thereof filed with the
Commission on or before the Effective Date that are incorporated by
reference in the Registration Statement or the Prospectus and any
documents or portions thereof filed with the Commission after the
Effective Date that are deemed to be incorporated by reference in
the Registration Statement or the Prospectus.
“Indebtedness” shall mean
(a) any liabilities for borrowed money or amounts owed in excess of
$500,000 (other than accrued liabilities and trade accounts payable
incurred in the ordinary course of business), (b) all guaranties,
endorsements and other contingent obligations in respect of
indebtedness of others, whether or not the same are or should be
reflected in the Company’s balance sheet (or the notes
thereto), except guaranties by endorsement of negotiable
instruments for deposit or collection or similar transactions in
the ordinary course of business and (c) the present value of any
lease payments in excess of $500,000 due under leases required to
be capitalized in accordance with GAAP.
2
“Intellectual Property
Rights” shall have
the meaning ascribed to such term in Section 3(v).
“Issuer Free Writing
Prospectus” shall mean an issuer free writing
prospectus, as defined in Rule 433.
“Liens” shall mean a lien,
charge, security interest, encumbrance, right of first refusal,
preemptive right or other restriction.
“Losses” shall have the
meaning ascribed to such term in Section 7(d).
“Material Adverse Effect”
shall have the meaning ascribed to such term in Section
3(b).
“Material Permits” shall
have the meaning ascribed to such term in Section
3(t).
“Maximum Amount” shall
have the meaning ascribed to such term in Section 2.
“Net Proceeds” shall have
the meaning ascribed to such term in Section 2(b)(v).
“Permitted Free Writing
Prospectus” shall have the meaning ascribed to such
term in Section 4(g).
“Person” shall mean an
individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or
subdivision thereof) or other entity of any kind, including the
Trading Market.
“Placement” shall have the
meaning ascribed to such term in Section 2(c).
“Proceeding” shall mean
any action, claim, suit, investigation or proceeding (including,
without limitation, an investigation or partial proceeding, such as
a deposition), whether commenced or threatened.
“Prospectus” shall mean
the Base Prospectus, as supplemented by the most recently filed
Prospectus Supplement (if any).
“Prospectus Supplement”
shall mean each prospectus supplement relating to the Shares
prepared and filed pursuant to Rule 424(b) from time to
time.
“Registration Statement”
shall mean the shelf registration statement (File Number
333-230755) on Form S-3, including exhibits and financial
statements and any prospectus supplement relating to the Shares
that is filed with the Commission pursuant to Rule 424(b) and
deemed part of such registration statement pursuant to Rule 430B,
as amended on each Effective Date and, in the event any
post-effective amendment thereto becomes effective, shall also mean
such registration statement as so amended.
3
“Representation Date”
shall have the meaning ascribed to such term in Section
4(k).
“Required Approvals” shall
have the meaning ascribed to such term in Section
3(e).
“Rule 158”,
“Rule
164”, “Rule 172”,
“Rule
173”, “Rule 405”,
“Rule
415”, “Rule 424”,
“Rule
430B” and “Rule 433” refer to such
rules under the Act.
“Sales Notice” shall have
the meaning ascribed to such term in Section 2(b)(i).
“SEC Reports” shall have
the meaning ascribed to such term in Section 3(m).
“Settlement Date” shall
have the meaning ascribed to such term in Section
2(b)(vii).
“Shares” shall have the
meaning ascribed to such term in Section 2.
“Subsidiary” shall have
the meaning ascribed to such term in Section 3(a).
“Terms Agreement” shall
have the meaning ascribed to such term in Section
2(a).
“Time of Delivery” shall
have the meaning ascribed to such term in Section
2(c).
“Trading Market” means
Nasdaq Capital Market.
2. Sale and Delivery of Shares.
The Company proposes to issue and sell through or to the Manager,
as sales agent and/or principal, up to $100 million of shares (the
“Shares”) of the
Company’s common stock, $0.001 par value (“Common Stock”), from time
to time during the term of this Agreement and on the terms set
forth herein; provided, however, that in no event shall
the Company issue or sell through the Manager such number of Shares
that (a) exceeds the number or dollar amount of shares of Common
Stock registered on the Registration Statement, pursuant to which
the offering is being made, (b) exceeds the number of authorized
but unissued shares of Common Stock or (c) would cause the Company
or the offering of the Shares to not satisfy the eligibility and
transaction requirements for use of Form S-3 (including, if
applicable, General Instruction I.B.6 of Registration Statement on
Form S-3 (the lesser of (a), (b) and (c), the “Maximum Amount”)).
Notwithstanding anything to the contrary contained herein, the
parties hereto agree that compliance with the limitations set forth
in this Section 2 on the number and aggregate sales price of Shares
issued and sold under this Agreement shall be the sole
responsibility of the Company and that the Manager shall have no
obligation in connection with such compliance.
4
(a) Appointment of Manager as Selling
Agent; Term Agreement. For purposes of selling the Shares
through the Manager pursuant to this Agreement, the Company hereby
appoints the Manager as exclusive agent of the Company and the
Manager agrees to use its commercially reasonable efforts to sell
the Shares on the terms and subject to the conditions stated
herein. The Company agrees that, whenever it determines to sell the
Shares directly to the Manager as principal, it will enter into a
separate agreement (each, a “Terms Agreement”) in
substantially the form of Annex I hereto, relating to
such sale in accordance with Section 2 of this
Agreement.
(b) Agent Sales. Subject to the
terms and conditions and in reliance upon the representations and
warranties herein set forth, the Company will issue and agrees to
sell Shares, from time to time, through the Manager, acting as
sales agent, and the Manager agrees to use its commercially
reasonable efforts to sell, as sales agent for the Company, on the
following terms:
(i) The Shares are to
be sold on a daily basis or otherwise as shall be agreed to by the
Company and the Manager on any day that (A) is a trading day for
the Trading Market, (B) the Company has instructed the Manager by
telephone (confirmed promptly by electronic mail) to make such
sales (“Sales
Notice”) and (C) the Company has satisfied its
obligations under Section 6 of this Agreement. The Company will
designate the maximum amount of the Shares to be sold by the
Manager daily (subject to the limitations set forth in Section
2(d)) and the minimum price per Share at which such Shares may be
sold. Subject to the terms and conditions hereof, the Manager shall
use its commercially reasonable efforts to sell on a particular day
all of the Shares designated for sale by the Company on such day.
The gross sales price of the Shares sold under this Section 2(b)
shall be the market price for shares of the Company’s Common
Stock sold by the Manager under this Section 2(b) on the Trading
Market at the time of sale of such Shares.
(ii) The
Company acknowledges and agrees that (A) there can be no assurance
that the Manager will be successful in selling the Shares, (B) the
Manager will incur no liability or obligation to the Company or any
other Person or entity if it does not sell the Shares for any
reason other than a failure by the Manager to use its commercially
reasonable efforts consistent with its normal trading and sales
practices and applicable law and regulations to sell such Shares as
required under this Agreement and (C) the Manager shall be under no
obligation to purchase Shares on a principal basis pursuant to this
Agreement, except as otherwise specifically agreed by the Manager
and the Company pursuant to a Terms Agreement.
5
(iii) The
Company shall not authorize the issuance and sale of, and the
Manager shall not be obligated to use its commercially reasonable
efforts to sell, any Share at a price lower than the minimum price
therefor designated, from time to time, by the Company’s
Board of Directors (the “Board”), or a duly
authorized committee thereof, or such duly authorized officers of
the Company, and notified to the Manager in writing. The Company or
the Manager may, upon notice to the other party hereto by telephone
(confirmed promptly by electronic mail), suspend the offering of
the Shares for any reason and at any time; provided, however, that such suspension
or termination shall not affect or impair the parties’
respective obligations with respect to the Shares sold hereunder
prior to the giving of such notice.
(iv) The
Manager may sell Shares by any method permitted by law deemed to be
an “at the market offering” as defined in Rule 415
under the Act, including, without limitation, sales made directly
on the Trading Market, on any other existing trading market for the
Common Stock or to or through a market maker. The Manager may also
sell Shares in privately negotiated transactions, provided that the
Manager receives the Company’s prior written approval for any
sales in privately negotiated transactions and if so provided in
the “Plan of Distribution” section of the Prospectus
Supplement.
(v) The compensation to
the Manager for sales of the Shares under this Section 2(b) shall
be a placement fee of 3% of the gross sales price of the Shares
sold pursuant to this Section 2(b) up to $30.0 million and 2.5% of
the gross sales price of the Shares sold pursuant to this Section
2(b) in excess of $30.0 million (“Broker Fee”). The
foregoing rate of compensation shall not apply when the Manager
acts as principal, in which case the Company may sell Shares to the
Manager as principal at a price agreed upon at the relevant
Applicable Time pursuant to a Terms Agreement. The remaining
proceeds, after deduction of the Broker Fee and deduction for any
transaction fees imposed by any clearing firm, execution broker, or
governmental or self-regulatory organization in respect of such
sales, shall constitute the net proceeds to the Company for such
Shares (the “Net
Proceeds”).
(vi) The
Manager shall provide written confirmation (which may be by
facsimile or electronic mail) to the Company following the close of
trading on the Trading Market each day in which the Shares are sold
under this Section 2(b) setting forth the number of the Shares sold
on such day, the aggregate gross sales proceeds and the Net
Proceeds to the Company, and the compensation payable by the
Company to the Manager with respect to such sales.
6
(vii) Upon
delivery of a Sales Notice, the Company shall issue and deliver the
maximum number of Shares to be sold pursuant to the Sales Notice to
the Manager’s account at The Depository Trust Company
(“DTC”)
via the DWAC system, which Shares shall be deposited by the Manager
in the Company’s account with the Manager. The Manager shall
have no obligation to attempt to sell the Shares until the Company
has delivered the Shares to the Manager. Settlement for sales of
the Shares pursuant to this Section 2(b) will occur at 10:00 a.m.
(New York City time), or at such time as the Company and the
Manager may mutually agree, on the second Business Day following
delivery of the Shares issued pursuant to the Sales Notice (each
such day, a “Settlement Date”). On
each Settlement Date, the Manager shall deliver the Net Proceeds
from the sale of the Shares to the Company. If on any Settlement
Date not all Shares were sold as issued pursuant to the Sales
Notice, then, at the election of and upon notice from the Company,
the Shares shall be applied to a future Settlement Date or returned
to the Company.
(viii) At
each Applicable Time, Settlement Date, Representation Date and
Filing Date, the Company shall be deemed to have affirmed each
representation and warranty contained in this Agreement as if such
representation and warranty were made as of such date, modified as
necessary to relate to the Registration Statement and the
Prospectus, as amended as of such date. Any obligation of the
Manager to use its commercially reasonable efforts to sell the
Shares on behalf of the Company shall be subject to the continuing
accuracy of the representations and warranties of the Company
herein, to the performance by the Company of its obligations
hereunder and to the continuing satisfaction of the additional
conditions specified in Section 6 of this Agreement.
(c) Term Sales. If the Company
wishes to sell the Shares pursuant to this Agreement but other than
as set forth in Section 2(b) of this Agreement (each, a
“Placement”), it will
notify the Manager of the proposed terms of such Placement. If the
Manager, acting as principal, wishes to accept such proposed terms
(which it may decline to do for any reason in its sole discretion)
or, following discussions with the Company, wishes to accept
amended terms, the Manager and the Company will enter into a Terms
Agreement setting forth the terms of such Placement. The terms set
forth in a Terms Agreement will not be binding on the Company or
the Manager unless and until the Company and the Manager have each
executed such Terms Agreement accepting all of the terms of such
Terms Agreement. In the event of a conflict between the terms of
this Agreement and the terms of a Terms Agreement, the terms of
such Terms Agreement will control. A Terms Agreement may also
specify certain provisions relating to the reoffering of such
Shares by the Manager. The commitment of the Manager to purchase
the Shares pursuant to any Terms Agreement shall be deemed to have
been made on the basis of the representations and warranties of the
Company herein contained and shall be subject to the terms and
conditions herein set forth. Each Terms Agreement shall specify the
number of the Shares to be purchased by the Manager pursuant
thereto, the price to be paid to the Company for such Shares, any
provisions relating to rights of, and default by, underwriters
acting together with the Manager in the reoffering of the Shares,
and the time and date (each such time and date being referred to
herein as a “Time of
Delivery”) and place of delivery of and payment for
such Shares. Such Terms Agreement shall also specify any
requirements for opinions of counsel, accountants’ letters
and officers’ certificates pursuant to Section 6 of this
Agreement and any other information or documents required by the
Manager.
7
(d) Maximum Number of Shares. Under
no circumstances shall the Company cause or request the offer or
sale of any Shares if, after giving effect to the sale of such
Shares, the aggregate amount of Shares sold pursuant to this
Agreement would exceed the lesser of (A) together with all sales of
Shares under this Agreement, the Maximum Amount, (B) the amount
available for offer and sale under the currently effective
Registration Statement and (C) the amount authorized, from time to
time, to be issued and sold under this Agreement by the Board, a
duly authorized committee thereof or a duly authorized executive
committee, and notified to the Manager in writing. Under no
circumstances shall the Company cause or request the offer or sale
of any Shares pursuant to this Agreement at a price lower than the
minimum price authorized, from time to time, by the Board, a duly
authorized committee thereof or a duly authorized executive
committee, and notified to the Manager in writing. Further, under
no circumstances shall the Company cause or permit the aggregate
offering amount of Shares sold pursuant to this Agreement to exceed
the Maximum Amount.
(e) Regulation M Notice. Unless the
exceptive provisions set forth in Rule 101(c)(1) of Regulation M
under the Exchange Act are satisfied with respect to the Shares,
the Company shall give the Manager at least one Business
Day’s prior notice of its intent to sell any Shares in order
to allow the Manager time to comply with Regulation M.
3. Representations and Warranties.
The Company represents and warrants to, and agrees with, the
Manager at the Execution Time and on each such time the following
representations and warranties are repeated or deemed to be made
pursuant to this Agreement, as set forth below or in the
Registration Statement, the Prospectus or the Incorporated
Documents.
(a) Subsidiaries.
All of the direct and indirect subsidiaries (individually, a
“Subsidiary”,
and collectively, the “Subsidiaries”)
of the Company are set forth on Exhibit 21.1 to the Company’s
most recent Annual Report on Form 10-K filed with the Commission.
Except as otherwise disclosed in the SEC Reports, the Company owns,
directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens. All of
the issued and outstanding shares of capital stock of each
Subsidiary are validly issued and are fully paid, non-assessable
and free of preemptive and similar rights to subscribe for or
purchase securities.
8
(b) Organization and
Qualification. The Company and
each of the Subsidiaries is an entity duly incorporated or
otherwise organized, validly existing and in good standing under
the laws of the jurisdiction of its incorporation or organization
(as applicable), with the requisite power and authority to own and
use its properties and assets and to carry on its business as
currently conducted. Neither the Company nor any Subsidiary is in
violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other
organizational or charter documents. Each of the Company and the
Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each
jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except
where the failure to be so qualified or in good standing, as the
case may be, could not reasonably be expected to result in (i) a
material adverse effect on the legality, validity or enforceability
of this Agreement, (ii) a material adverse change in the results of
operations, assets, business, prospects or condition (financial or
otherwise) of the Company and the Subsidiaries, taken as a whole,
from that set forth in the Registration Statement, the Base
Prospectus, any Prospectus Supplement, the Prospectus or the
Incorporated Documents or (iii) a material adverse effect on the
Company’s ability to perform in any material respect on a
timely basis its obligations under this Agreement (any of (i), (ii)
or (iii), a “Material Adverse
Effect”) and no
Proceeding has been instituted in any such jurisdiction revoking,
limiting or curtailing or seeking to revoke, limit or curtail such
power and authority or qualification.
(c) Authorization and
Enforcement. The Company has
the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by this Agreement and
otherwise to carry out its obligations hereunder. The execution and
delivery of this Agreement by the Company and the consummation by
it of the transactions contemplated hereby have been duly
authorized by all necessary action on the part of the Company and
no further action is required by the Company, the Board or its
stockholders in connection herewith other than in connection with
the Required Approvals. This Agreement has been duly executed and
delivered by the Company and constitutes the valid and binding
obligation of the Company enforceable against the Company in
accordance with its terms except (i) as limited by general
equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application
affecting enforcement of creditors’ rights generally, (ii) as
limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and
(iii) insofar as indemnification and contribution provisions may be
limited by applicable law.
9
(d) No
Conflicts. The execution,
delivery and performance of this Agreement by the Company, the
issuance and sale of the Shares and the consummation by the Company
of the other transactions contemplated herein do not and will not
(i) conflict with or violate any provision of the Company’s
or any Subsidiary’s certificate or articles of incorporation,
bylaws or other organizational or charter documents, (ii) conflict
with, or constitute a default (or an event that with notice or
lapse of time or both would become a default) under, result in the
creation of any Lien upon any of the properties or assets of the
Company or any Subsidiary, or give to others any rights of
termination, amendment, acceleration or cancellation (with or
without notice, lapse of time or both) of, any agreement, credit
facility, debt or other instrument (evidencing a Company or
Subsidiary debt or otherwise) or other understanding to which the
Company or any Subsidiary is a party or by which any property or
asset of the Company or any Subsidiary is bound or affected or
(iii) subject to the Required Approvals, conflict with or result in
a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is
subject (including federal and state securities laws and
regulations), or by which any property or asset of the Company or a
Subsidiary is bound or affected, except in the case of each of
clauses (ii) and (iii), such as could not reasonably be expected to
result in a Material Adverse Effect.
(e) Filings, Consents and
Approvals. The Company is not
required to obtain any consent, waiver, authorization or order of,
give any notice to, or make any filing or registration with, any
court or other federal, state, local or other governmental
authority or other Person in connection with the execution,
delivery and performance by the Company of this Agreement, other
than (i) the filings required by this Agreement, (ii) the filing
with the Commission of the Prospectus Supplement, (iii) the filing
of application(s) to, and approval by, the Trading Market for the
listing of the Shares for trading thereon in the time and manner
required thereby and (iv) such filings as are required to be made
under applicable state securities laws and the rules and
regulations of the Financial Industry Regulatory Authority, Inc.
(“FINRA”)
(collectively, the “Required
Approvals”).
(f) Issuance of
Shares. The Shares are duly
authorized and, when issued and paid for in accordance with this
Agreement, will be duly and validly issued, fully paid and
nonassessable, free and clear of all Liens imposed by the Company.
The Company has reserved from its duly authorized capital stock the
maximum number of shares of Common Stock issuable pursuant to this
Agreement. The issuance by the Company of the Shares has been
registered under the Act and all of the Shares are freely
transferable and tradable by the purchasers thereof without
restriction (other than any restrictions arising solely from an act
or omission of such a purchaser). The Shares are being issued
pursuant to the Registration Statement and the issuance of the
Shares has been registered by the Company under the Act. The
“Plan of Distribution” section within the Registration
Statement permits the issuance and sale of the Shares as
contemplated by this Agreement. Upon receipt of the Shares, the
purchasers of such Shares will have good and marketable title to
such Shares and the Shares will be freely tradable on the Trading
Market.
10
(g) Capitalization.
The capitalization of the Company is as set forth in the
Registration Statement, the Base Prospectus, the Prospectus
Supplement and the Prospectus. The Company has not issued any
capital stock since its most recently filed periodic report under
the Exchange Act, other than pursuant to the exercise of employee
stock options under the Company’s stock option plans, the
issuance of shares of Common Stock to employees pursuant to the
Company’s employee stock purchase plan and pursuant to the
conversion or exercise of securities exercisable, exchangeable or
convertible into Common Stock (“Common Stock
Equivalents”) or other
than as disclosed in the Registration Statement, the Base
Prospectus, the Prospectus Supplement and the Prospectus. No Person
has any right of first refusal, preemptive right, right of
participation, or any similar right to participate in the
transactions contemplated by this Agreement. Except (i) pursuant to
the Company’s stock option plans and (ii) pursuant to
agreements or instruments filed as exhibits to Incorporated
Documents, there are no outstanding options, warrants, script
rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any
Person any right to subscribe for or acquire, any shares of Common
Stock, or contracts, commitments, understandings or arrangements by
which the Company or any Subsidiary is or may become bound to issue
additional shares of Common Stock or Common Stock Equivalents. The
issuance and sale of the Shares will not obligate the Company to
issue shares of Common Stock or other securities to any Person and
will not result in a right of any holder of Company securities to
adjust the exercise, conversion, exchange or reset price under such
securities. All of the outstanding shares of capital stock of the
Company are validly issued, fully paid and nonassessable, have been
issued in compliance with all federal and state securities laws,
and none of such outstanding shares was issued in violation of any
preemptive rights or similar rights to subscribe for or purchase
securities. There are no stockholders agreements, voting agreements
or other similar agreements with respect to the Company’s
capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company’s
stockholders.
11
(h) Registration Statement;
Prospectus. The Company meets the requirements for use of
Form S-3 under the Act and has prepared and filed with the
Commission the Registration Statement, including a related Base
Prospectus, for registration under the Act of the offering and sale
of the Shares. Such Registration Statement is effective and
available for the offer and sale of the Shares as of the date
hereof. As filed, the Base Prospectus contains all information
required by the Act and the rules thereunder, and, except to the
extent the Manager shall agree in writing to a modification, shall
be in all substantive respects in the form furnished to the Manager
prior to the Execution Time or prior to any such time this
representation is repeated or deemed to be made. The Registration
Statement, at the Execution Time, each such time this
representation is repeated or deemed to be made and at all times
during which a prospectus is required by the Act to be delivered
(whether physically or through compliance with Rule 172, Rule 173
or any similar rule) in connection with any offer or sale of the
Shares, meets the requirements set forth in Rule 415(a)(1)(x). The
initial Effective Date of the Registration Statement was not
earlier than the date three years before the Execution Time. The
Registration Statement, when it became effective, and the
Prospectus, and any amendment or supplement thereto, on the date of
such Prospectus or amendment or supplement, conformed and will
conform in all material respects with the requirements of the Act.
At each Settlement Date, the Registration Statement and the
Prospectus, as of such date, will conform in all material respects
with the requirements of the Act. The Registration Statement, when
it became or becomes effective, did not and will not contain an
untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the
statements therein not misleading. The Prospectus and any amendment
and supplement thereto, on the date thereof and at each Applicable
Time, did not or will not include an untrue statement of a material
fact or omit to state a material fact necessary to make the
statements therein, in light of the circumstances under which they
were made, not misleading. The Prospectus delivered to the Manager
for use in connection with the sale of the Shares pursuant to this
Agreement will be identical to the versions of the Prospectus
created to be transmitted to the Commission for filing via XXXXX,
except to the extent permitted by Regulation S-T.
(i) Accuracy of
Incorporated Documents. The
Incorporated Documents, when they were filed with the Commission,
conformed in all material respects to the requirements of the
Exchange Act and the rules thereunder, and none of the Incorporated
Documents, when they were filed with the Commission, contained any
untrue statement of a material fact or omitted to state a material
fact necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading, and any
further documents so filed and incorporated by reference in the
Registration Statement, the Base Prospectus, the Prospectus
Supplement or the Prospectus, when such documents are filed with
the Commission, will conform in all material respects to the
requirements of the Exchange Act and the rules thereunder, as
applicable, and will not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the
statements therein, in light of the circumstances under which they
were made, not misleading.
12
(j) Ineligible Issuer. (i) At the
earliest time after the filing of the Registration Statement that
the Company or another offering participant made a bona fide offer
(within the meaning of Rule 164(h)(2)) of the Shares and (ii) as of
the Execution Time and on each such time this representation is
repeated or deemed to be made (with such date being used as the
determination date for purposes of this clause (ii)), the Company
was not and is not an Ineligible Issuer (as defined in Rule 405),
without taking account of any determination by the Commission
pursuant to Rule 405 that it is not necessary that the Company be
considered an Ineligible Issuer (as defined in Rule
405).
(k) Free Writing Prospectus. The
Company is eligible to use Issuer Free Writing Prospectuses. Each
Issuer Free Writing Prospectus does not include any information the
substance of which conflicts with the information contained in the
Registration Statement, including any Incorporated Documents and
any Prospectus Supplement deemed to be a part thereof that has not
been superseded or modified, and each Issuer Free Writing
Prospectus does not contain any untrue statement of a material fact
or omit to state any material fact necessary in order to make the
statements therein, in light of the circumstances under which they
were made, not misleading. The foregoing sentence does not apply to
statements in, or omissions from, any Issuer Free Writing
Prospectus based upon and in conformity with written information
furnished to the Company by the Manager specifically for use
therein. Any Issuer Free
Writing Prospectus that the Company is
required to file pursuant to Rule 433(d) has been, or will be,
filed with the Commission in accordance with the requirements of
the Act and the rules thereunder. Each Issuer Free Writing
Prospectus that the Company has filed,
or is required to file, pursuant to Rule 433(d) or that was
prepared by or behalf of, or used by, the Company complies or will
comply in all material respects with the requirements of the Act
and the rules thereunder. The Company will not, without the prior
consent of the Manager, prepare, use or refer to any Issuer Free
Writing Prospectuses.
(l) Proceedings Related to Registration
Statement. The Registration Statement is not the subject of
a pending proceeding or examination under Section 8(d) or Section
8(e) of the Act and the Company is not the subject of a pending
proceeding under Section 8A of the Act in connection with the
offering of the Shares. The Company
has not received any notice that the Commission has issued or
intends to issue a stop order with respect to the Registration
Statement or that the Commission otherwise has suspended or
withdrawn the effectiveness of the Registration Statement, either
temporarily or permanently, or intends or has threatened in writing
to do so.
13
(m) SEC
Reports. The Company has
complied in all material respects with requirements to file all
reports, schedules, forms, statements and other documents required
to be filed by it under the Act and the Exchange Act, including
pursuant to Section 13(a) or 15(d) thereof, for the two years
preceding the date hereof (or such shorter period as the Company
was required by law to file such material) (the foregoing
materials, including the exhibits thereto and documents
incorporated by reference therein, being collectively referred to
herein as the “SEC
Reports”) on a timely
basis or has received a valid extension of such time of filing and
has filed any such SEC Reports prior to the expiration of any such
extension.
(n) Financial Statements. The
consolidated financial statements incorporated by reference in the
Registration Statement, the Prospectus or the Incorporated
Documents and any amendments thereof or supplements thereto
comply in all material respects with
applicable accounting requirements and the rules and regulations of
the Commission with respect thereto as in effect at the time of
filing or as amended or corrected in a subsequent filing. Such
financial statements have been prepared in accordance with United
States generally accepted accounting principles
(“GAAP”)
applied on a consistent basis during the periods involved, except
as may be otherwise specified in such financial statements or the
notes thereto and except that unaudited financial statements may
not contain all footnotes required by GAAP, and fairly present in
all material respects the financial position of the Company and its
consolidated subsidiaries as of and for the dates thereof and the
results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal,
immaterial, year-end audit adjustments.
(o) Accountants. The Company’s accountants are Accell Audit
& Compliance, PA and Deloitte & Touche LLP with respect to
Morinda Holdings, Inc. (the “Accountants”).
To the knowledge of the Company, such Accountants, are a registered
public accounting firm as required by the Act.
(p) Material Adverse
Events. Since the date of the
latest audited financial statements included within the SEC
Reports, except as specifically disclosed in a subsequent SEC
Report filed prior to the date hereof, (i) there has been no event,
occurrence or development that has had, or that could reasonably be
expected to result in, a Material Adverse Effect, (ii) the Company
has not incurred any liabilities (contingent or otherwise) other
than (A) trade payables and accrued expenses incurred in the
ordinary course of business consistent with past practice and (B)
liabilities not required to be reflected in the Company’s
financial statements pursuant to GAAP or required to be disclosed
in filings made with the Commission, (iii) the Company has not
altered its method of accounting, (iv) the Company has not declared
or made any dividend or distribution of cash or other property to
its stockholders or purchased, redeemed or made any agreements to
purchase or redeem any shares of its capital stock and (v) the
Company has not issued any equity securities to any officer,
director or Affiliate, except pursuant to existing Company stock
option plans. The Company does not have pending before the
Commission any request for confidential treatment of information.
No event, liability or development has occurred or exists with
respect to the Company or the Subsidiaries or their respective
business, properties, operations or financial condition, that would
be required to be disclosed by the Company under applicable
securities laws at the time this representation is deemed made,
that has not been publicly disclosed at least one trading day prior
to the date that this representation is deemed
made.
14
(q) Litigation.
There is no action, suit, inquiry, notice of violation, Proceeding
or investigation pending, or, to the knowledge of the Company,
threatened against or affecting, the Company, any Subsidiary or any
of their respective properties before or by any court, arbitrator,
governmental or administrative agency or regulatory authority
(federal, state, county, local or foreign) (collectively, an
“Action”)
which (i) adversely affects or challenges the legality, validity or
enforceability of this Agreement or the Shares or (ii) could, if
there were an unfavorable decision, reasonably be expected to
result in a Material Adverse Effect. Neither the Company nor any
Subsidiary, nor, to the knowledge of the Company, any director or
officer thereof, is or has been the subject of any Action involving
a claim of violation of, or liability under, federal or state
securities laws or a claim of breach of fiduciary duty. There has
not been, and to the knowledge of the Company, there is not pending
or contemplated, any investigation by the Commission involving the
Company or any current or former director or officer of the
Company. The Commission has not issued any stop order or other
order suspending the effectiveness of any registration statement
filed by the Company or any Subsidiary under the Exchange Act or
the Act.
(r) Labor
Relations. No material labor
dispute exists or, to the knowledge of the Company, is imminent
with respect to any of the employees of the Company which could
reasonably be expected to result in a Material Adverse Effect. None
of the Company’s or the Subsidiaries’ employees is a
member of a union that relates to such employee’s
relationship with the Company, and neither the Company nor any of
the Subsidiaries is a party to a collective bargaining agreement,
and the Company and the Subsidiaries believe that their
relationships with their employees are good. No executive officer,
to the knowledge of the Company, is, or is now expected to be, in
violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement or
non-competition agreement, or any other contract or agreement or
any restrictive covenant, and the continued employment of each such
executive officer does not subject the Company or any of the
Subsidiaries to any liability with respect to any of the foregoing
matters. The Company and the Subsidiaries are in compliance with
all federal, state, local and foreign laws and regulations relating
to employment and employment practices, terms and conditions of
employment and wages and hours, except where the failure to be in
compliance could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.
(s) No Existing
Defaults. Neither the Company
nor any Subsidiary (i) is in default under or in violation of (and
no event has occurred that has not been waived that, with notice or
lapse of time or both, would result in a default by the Company or
any Subsidiary under), nor has the Company or any Subsidiary
received notice of a claim that it is in default under or that it
is in violation of, any indenture, loan or credit agreement or any
other agreement or instrument to which it is a party or by which it
or any of its properties is bound (whether or not such default or
violation has been waived), (ii) is in violation of any order of
any court, arbitrator or governmental body or (iii) is or has been
in violation of any statute, rule or regulation of any governmental
authority, including, without limitation, all federal, state, local
and foreign laws and regulations relating to taxes, environmental
protection, occupational health and safety, product quality and
safety and employment and labor matters, except in each case as
could not reasonably be expected to result in a Material Adverse
Effect.
15
(t) Regulatory
Permits. The Company and the
Subsidiaries possess all certificates, authorizations and permits
issued by the appropriate federal, state, local or foreign
regulatory authorities necessary to conduct their respective
businesses as described in the Registration Statement, the Base
Prospectus, any Prospectus Supplement or the Prospectus, except
where the failure to possess such permits could not reasonably be
expected to result in a Material Adverse Effect
(“Material
Permits”), and neither
the Company nor any Subsidiary has received any notice of
proceedings relating to the revocation or modification of any
Material Permit. For clarity, the Company has not received the
approval of any regulatory agency to market any of its product
candidates.
(u) Title to
Assets. The Company and the
Subsidiaries have good and marketable title in fee simple to all
real property owned by them that is material to the business of the
Company and the Subsidiaries and good and marketable title in all
personal property owned by them that is material to the business of
the Company and the Subsidiaries, in each case free and clear of
all Liens, except for Liens disclosed in the SEC Reports and as do
not materially affect the value of such property and do not
materially interfere with the use made and proposed to be made of
such property by the Company and the Subsidiaries and Liens for the
payment of federal, state or other taxes, the payment of which is
neither delinquent nor subject to penalties. Any real property and
facilities held under lease by the Company and the Subsidiaries are
held by them under valid, subsisting and enforceable leases of
which the Company and the Subsidiaries are in compliance, except
where such non-compliance would not reasonably be expected to have
a Material Adverse Effect.
(v) Intellectual
Property. The Company and the
Subsidiaries have, or have rights to use, all patents, patent
applications, trademarks, trademark applications, service marks,
trade names, trade secrets, inventions, copyrights, licenses and
other similar intellectual property rights necessary or material
for use in connection with their respective businesses as described
in the Registration Statement, the Base Prospectus, any Prospectus
Supplement or the Prospectus and which the failure to so have could
reasonably be expected to have a Material Adverse Effect
(collectively, the “Intellectual Property
Rights”). Neither the
Company nor any Subsidiary has received, since the date of the
latest audited financial statements included within the SEC
Reports, a notice (written or otherwise) that the Intellectual
Property Rights violate or infringe upon the rights of any Person,
except as would not have a Material Adverse Effect. To the
knowledge of the Company, all such Intellectual Property Rights are
enforceable (other than patent and trademark applications) and
there is no existing infringement by another Person of any of the
Intellectual Property Rights. The Company and the Subsidiaries have
taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their Intellectual Property
Rights, except where failure to do so could not, individually or in
the aggregate, reasonably be expected to have a Material Adverse
Effect.
16
(w) Insurance.
The Company and the Subsidiaries are insured by insurers of
recognized financial responsibility against such losses and risks
and in such amounts as are prudent and customary for companies of
similar size as the Company in the businesses in which the Company
and the Subsidiaries are engaged, including, but not limited to,
directors and officers insurance coverage. To the knowledge of the
Company, such insurance contracts and policies are accurate and
complete. Neither the Company nor any Subsidiary has any reason to
believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar
coverage from similar insurers as may be necessary to continue its
business without a significant increase in
cost.
(x) Affiliate
Transactions. Except as set
forth in the Registration Statement, the Base Prospectus, any
Prospectus Supplement or the Prospectus, none of the officers or
directors of the Company and, to the knowledge of the Company, none
of the employees of the Company is presently a party to any
transaction with the Company or any Subsidiary (other than for
services as employees, officers and directors), including any
contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or
personal property to or from, or otherwise requiring payments to or
from any officer, director or such employee or, to the knowledge of
the Company, any entity in which any officer, director, or any such
employee has a substantial interest or is an officer, director,
trustee or partner, in each case in excess of $120,000, other than
for (i) payment of salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the Company
and (iii) other employee benefits, including stock option
agreements under any stock option plan of the
Company.
(y) Sarbanes Oxley
Compliance. Except as disclosed
in the Registration Statement, the Base Prospectus, any Prospectus
Supplement or the Prospectus, the Company is in material compliance
with all provisions of the Xxxxxxxx-Xxxxx Act of 2002 which are
applicable to it as of the Effective Date. The Company and
the Subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that: (i) transactions
are executed in accordance with management’s general or
specific authorizations, (ii) transactions are recorded as
necessary to permit preparation of financial statements in
conformity with GAAP and to maintain asset accountability, (iii)
access to assets is permitted only in accordance with
management’s general or specific authorization and (iv) the
recorded accountability for assets is compared with the existing
assets at reasonable intervals and appropriate action is taken with
respect to any differences. The Company has established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) for the Company and designed such disclosure
controls and procedures to ensure that information required to be
disclosed by the Company in the reports it files or submits under
the Exchange Act is recorded, processed, summarized and reported
within the time periods specified in the Commission’s rules
and forms. The Company’s certifying officers have evaluated
the effectiveness of the Company’s disclosure controls and
procedures as of the end of the period covered by the
Company’s most recently filed periodic report under the
Exchange Act (such date, the “Evaluation Date”). The
Company presented in its most recently filed periodic report under
the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based
on their evaluations as of the Evaluation Date. Since the
Evaluation Date, there has been no change in the Company’s
internal control over financial reporting (as such term is defined
in the Exchange Act) that has materially affected, or is reasonably
likely to materially affect, the Company’s internal control
over financial reporting.
17
(z) Finder’s Fees. Other than
payments to be made to the Manager, no
brokerage or finder’s fees or commissions are or will be
payable by the Company to any broker, financial advisor or
consultant, finder, placement agent, investment banker, bank or
other Person with respect to the transactions contemplated by this
Agreement. The Manager shall have no obligation with respect to any
fees or with respect to any claims made by or on behalf of other
Persons for fees of a type contemplated in this Section that may be
due in connection with the transactions contemplated by this
Agreement.
(aa) No
Other Sales Agency Agreement. The Company has not entered
into any other sales agency agreements or other similar
arrangements with any agent or any other representative in respect
of at the market offerings of the Shares.
(bb) Regulation
M Compliance. The Company has
not, and to its knowledge no one acting on its behalf has, (i)
taken, directly or indirectly, any action designed to cause or to
result in the stabilization or manipulation of the price of any
security of the Company to facilitate the sale or resale of any of
the Shares, (ii) sold, bid for, purchased, or paid any compensation
for soliciting purchases of, any of the Shares or (iii) paid or
agreed to pay to any Person any compensation for soliciting another
to purchase any other securities of the Company, other than, in the
case of clauses (ii) and (iii), compensation paid to the Manager in
connection with the placement of the Shares.
(cc) Listing
and Maintenance Requirements.
The issuance and sale of the Shares as contemplated in this
Agreement does not contravene the rules and regulations of the
Trading Market. The Common
Stock is registered pursuant to Section 12(b) or 12(g) of the
Exchange Act, and the Company has taken no action designed to, or
which to its knowledge is likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act, nor
has the Company received any notification that the Commission is
contemplating terminating such registration. Except as disclosed in
the Registration Statement, the Base Prospectus, any Prospectus
Supplement or the Prospectus, the Company has not, in the 12 months
preceding the date hereof, received notice from any Trading Market
on which the Common Stock is or has been listed or quoted to the
effect that the Company is not in compliance with the listing or
maintenance requirements of such Trading
Market.
(dd) Application
of Takeover Protections. Except
as set forth in the Registration Statement, the Base Prospectus,
any Prospectus Supplement or the Prospectus, the Company and its
Board have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company’s
certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become
applicable to the purchasers of the Shares.
18
(ee) Investment
Company. The Company is not,
and is not an Affiliate of, and immediately after receipt of
payment for the Shares, will not be or be an Affiliate of, an
“investment company” within the meaning of the
Investment Company Act of 1940, as amended. The Company currently
intends to conduct its business in a manner so that it will not
become subject to the Investment Company Act of 1940, as
amended.
(ff) Solvency.
Based on the financial condition of the Company as of the Effective
Date, (i) the Company’s fair saleable value of its assets
exceeds the amount that will be required to be paid on or in
respect of the Company’s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii) the
Company’s assets do not constitute unreasonably small capital
to carry on its business as now conducted and as proposed to be
conducted, including its capital needs taking into account the
particular capital requirements of the business conducted by the
Company, and projected capital requirements and capital
availability thereof and (iii) the current cash flow of the
Company, together with the proceeds the Company would receive were
it to liquidate all of its assets, after taking into account all
anticipated uses of the cash, would be sufficient to pay all
amounts on or in respect of its debt when such amounts are required
to be paid. Within one year of the Effective Date, the Company does
not intend to incur debts beyond its ability to pay such debts as
they mature (taking into account the timing and amounts of cash to
be payable on or in respect of its debt). The SEC Reports set
forth, as of the dates thereof, all outstanding secured and
unsecured Indebtedness of the Company or any Subsidiary, or for
which the Company or any Subsidiary has commitments.
Neither the Company nor any Subsidiary is in
default with respect to any Indebtedness.
(gg) Tax
Status. Except for matters that
would not, individually or in the aggregate, have or reasonably be
expected to result in a Material Adverse Effect, the Company and
each Subsidiary has (i) made
or filed all
necessary foreign and United States federal, state and
local income and franchise tax returns and have paid or accrued all taxes shown as due
thereon, and the Company has no knowledge of a tax deficiency which
has been asserted or threatened against the Company
or, reports and declarations
required by any jurisdiction to which it is subject, (ii) paid all
taxes and other governmental assessments and charges that are
material in amount, shown or determined to be due on such returns,
reports and declarations and (iii) set aside on its books provision
reasonably adequate for the payment of all material taxes for
periods subsequent to the periods to which such returns, reports or
declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any
jurisdiction, and the officers of the Company or of
any Subsidiary know of no basis for any such
claim.
(hh) Foreign
Corrupt Practices. Neither the
Company, nor to the knowledge of the Company, any agent or other
Person acting on behalf of the Company, has (i) directly or
indirectly used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or
domestic political activity, (ii) made any unlawful payment to
foreign or domestic government officials or employees or to any
foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the
Company (or made by any Person acting on its behalf of which the
Company is aware) which is in violation of law or (iv) violated in
any material respect any provision of the Foreign Corrupt Practices
Act of 1977, as amended.
19
(ii) FINRA
Member Shareholders. There are
no affiliations with any FINRA member firm among the
Company’s officers, directors or, to the knowledge of the
Company, any five percent (5%) or greater stockholder of the
Company.
4. Agreements. The Company agrees
with the Manager that:
(a) Right to Review Amendments and
Supplements to Registration Statement and Prospectus. During
any period when the delivery of a prospectus relating to the Shares
is required (including in circumstances where such requirement may
be satisfied pursuant to Rule 172, Rule 173 or any similar rule) to
be delivered under the Act in connection with the offering or the
sale of Shares, the Company will not file any amendment to the
Registration Statement or supplement (including any Prospectus
Supplement) to the Base Prospectus unless the Company has furnished
to the Manager a copy for its review prior to filing and will not
file any such proposed amendment or supplement to which the Manager
reasonably objects. The Company has properly completed the
Prospectus, in a form approved by the Manager, and filed such
Prospectus, as amended at the Execution Time, with the Commission
pursuant to the applicable paragraph of Rule 424(b) by the
Execution Time and will cause any supplement to the Prospectus to
be properly completed, in a form approved by the Manager, and will
file such supplement with the Commission pursuant to the applicable
paragraph of Rule 424(b) within the time period prescribed thereby
and will provide evidence reasonably satisfactory to the Manager of
such timely filing. The Company will promptly advise the Manager
(i) when the Prospectus and any supplement thereto shall have been
filed (if required) with the Commission pursuant to Rule 424(b),
(ii) when, during any period when the delivery of a prospectus
(whether physically or through compliance with Rule 172, Rule 173
or any similar rule) is required under the Act in connection with
the offering or sale of the Shares, any amendment to the
Registration Statement shall have been filed or become effective
(other than any annual report of the Company filed pursuant to
Section 13(a) or 15(d) of the Exchange Act), (iii) of any request
by the Commission or its staff for any amendment of the
Registration Statement, or any Rule 462(b) Registration Statement,
or for any supplement to the Prospectus or for any additional
information, (iv) of the issuance by the Commission of any stop
order suspending the effectiveness of the Registration Statement or
of any notice objecting to its use, or the institution or
threatening of any proceeding for that purpose, and (v) of the
receipt by the Company of any notification with respect to the
suspension of the qualification of the Shares for sale in any
jurisdiction or the institution or threatening of any proceeding
for such purpose. The Company will use its best efforts to prevent
the issuance of any such stop order or the occurrence of any such
suspension or objection to the use of the Registration Statement
and, upon such issuance, occurrence or notice of objection, to
obtain as soon as possible the withdrawal of such stop order or
relief from such occurrence or objection, including, if necessary,
by filing an amendment to the Registration Statement or a new
registration statement and using its best efforts to have such
amendment or new registration statement declared effective as soon
as practicable.
20
(b) Subsequent Events. If, at any
time on or after an Applicable Time but prior to the related
Settlement Date, any event occurs as a result of which the
Registration Statement or the Prospectus would include any untrue
statement of a material fact or omit to state any material fact
necessary to make the statements therein, in light of the
circumstances under which they were made or the circumstances then
prevailing, not misleading, the Company will (i) notify promptly
the Manager so that any use of the Registration Statement or the
Prospectus may cease until such are amended or supplemented, (ii)
amend or supplement the Registration Statement or the Prospectus to
correct such statement or omission, and (iii) supply any amendment
or supplement to the Manager in such quantities as the Manager may
reasonably request.
(c) Notification of Subsequent
Filings. During any period when the delivery of a prospectus
relating to the Shares is required (including in circumstances
where such requirement may be satisfied pursuant to Rule 172, Rule
173 or any similar rule) to be delivered under the Act, any event
occurs as a result of which the Prospectus as then supplemented
would include any untrue statement of a material fact or omit to
state any material fact necessary to make the statements therein,
in light of the circumstances under which they were made, not
misleading, or if it shall be necessary to amend the Registration
Statement, file a new registration statement or supplement the
Prospectus to comply with the Act or the Exchange Act or the
respective rules thereunder, including in connection with use or
delivery of the Prospectus, the Company promptly will (i) notify
the Manager of any such event, (ii) subject to Section 4(a),
prepare and file with the Commission an amendment or supplement or
new registration statement which will correct such statement or
omission or effect such compliance, (iii) use its best efforts to
have any amendment to the Registration Statement or new
registration statement declared effective as soon as practicable in
order to avoid any disruption in use of the Prospectus and (iv)
supply any supplemented Prospectus to the Manager in such
quantities as the Manager may reasonably request.
(d) Earnings
Statements. As soon as practicable, the Company will make
generally available to its security holders and to the Manager an
earnings statement or statements of the Company and the
Subsidiaries which will satisfy the provisions of Section 11(a) of
the Act and Rule 158.
(e) Delivery of Registration
Statement. Upon the request of the Manager, the Company will
furnish to the Manager and counsel for the Manager, without charge,
signed copies of the Registration Statement (including exhibits
thereto) and, so long as delivery of a prospectus by the Manager or
dealer may be required by the Act (including in circumstances where
such requirement may be satisfied pursuant to Rule 172, Rule 173 or
any similar rule), as many copies of the Prospectus and each Issuer
Free Writing Prospectus and any supplement thereto as the Manager
may reasonably request. The Company will pay the expenses of
printing or other production of all documents relating to the
offering.
21
(f) Qualification of Shares. The
Company will arrange, if necessary, for the qualification of the
Shares for sale under the laws of such jurisdictions as the Manager
may designate and will maintain such qualifications in effect so
long as required for the distribution of the Shares; provided that in no event shall
the Company be obligated to qualify to do business in any
jurisdiction where it is not now so qualified or to take any action
that would subject it to service of process in suits, other than
those arising out of the offering or sale of the Shares, in any
jurisdiction where it is not now so subject.
(g) Free Writing Prospectus. The
Company agrees that, unless it has or shall have obtained the prior
written consent of the Manager, and the Manager agrees with the
Company that, unless it has or shall have obtained, as the case may
be, the prior written consent of the Company, it has not made and
will not make any offer relating to the Shares that would
constitute an Issuer Free Writing Prospectus or that would
otherwise constitute a “free writing prospectus” (as
defined in Rule 405) required to be filed by the Company with the
Commission or retained by the Company under Rule 433. Any such free
writing prospectus consented to by the Manager or the Company is
hereinafter referred to as a “Permitted Free Writing
Prospectus.” The Company agrees that (i) it has
treated and will treat, as the case may be, each Permitted Free
Writing Prospectus as an Issuer Free Writing Prospectus and (ii) it
has complied and will comply, as the case may be, with the
requirements of Rule 164 and Rule 433 applicable to any Permitted
Free Writing Prospectus, including in respect of timely filing with
the Commission, legending and record keeping.
(h) Subsequent Equity Issuances.
Neither the Company nor any Subsidiary will offer, sell, issue,
contract to sell, contract to issue or otherwise dispose of,
directly or indirectly, any other shares of Common Stock or any
Common Stock Equivalents (other than the Shares) during the term of
this Agreement without the prior written consent of the Manager (i)
without giving the Manager at least three Business Days’
prior written notice specifying the nature of the proposed
transaction and the date of such proposed transaction and (ii)
unless the Manager suspends acting under this Agreement for such
period of time requested by the Company or as deemed appropriate by
the Manager in light of the proposed transaction; provided, however, that the Company may
issue and sell Common Stock pursuant to any employee stock option
plan, stock ownership plan or dividend reinvestment plan of the
Company, upon the conversion or exercise of Common Stock
Equivalents outstanding at the Execution Time or pursuant to any
other agreement in effect at the Execution Time or as compensation
for services rendered and, with as much notice as reasonably
practicable, the Company may issue Common Stock issuable upon the
conversion or exercise of Common Stock Equivalents outstanding at
the Execution Time.
(i) Market Manipulation. Until the
termination of this Agreement, the Company will not take, directly
or indirectly, any action designed to or that would constitute or
that might reasonably be expected to cause or result in, under the
Exchange Act or otherwise, stabilization or manipulation in
violation of the Act, Exchange Act or the rules and regulations
thereunder of the price of any security of the Company to
facilitate the sale or resale of the Shares or otherwise violate
any provision of Regulation M under the Exchange Act.
22
(j) Notification of Incorrect
Certificate. The Company will, at any time during the term
of this Agreement, as supplemented from time to time, advise the
Manager immediately after it shall have received notice or obtained
knowledge thereof, of any information or fact that would alter or
affect any opinion, certificate, letter and other document provided
to the Manager pursuant to Section 6 herein.
(k) Certification of Accuracy of
Disclosure. Upon commencement of the offering of the Shares
under this Agreement (and upon the recommencement of the offering
of the Shares under this Agreement following the termination of a
suspension of sales hereunder lasting more than 30 trading days),
and each time that (i) the Registration Statement or the Prospectus
shall be amended or supplemented, other than by means of
Incorporated Documents, (ii) the Company files its Annual Report on
Form 10-K under the Exchange Act, (iii) the Company files its
Quarterly Reports on Form 10-Q under the Exchange Act, (iv) the
Company files a Current Report on Form 8-K containing amended
financial information (other than information that is furnished and
not filed), if the Manager reasonably determines that the
information in such Form 8-K is material or (v) the Shares are
delivered to the Manager as principal at the Time of Delivery
pursuant to a Terms Agreement (such commencement or recommencement
date and each such date referred to in clauses (i), (ii), (iii),
(iv) and (v) above, a “Representation Date”),
unless waived by the Manager, the Company shall furnish or cause to
be furnished to the Manager forthwith a certificate dated and
delivered on the Representation Date, in form reasonably
satisfactory to the Manager, to the effect that the statements
contained in the certificate referred to in Section 6 of this
Agreement which were last furnished to the Manager are true and
correct at the Representation Date, as though made at and as of
such date (except that such statements shall be deemed to relate to
the Registration Statement and the Prospectus, as amended and
supplemented to such date) or, in lieu of such certificate, a
certificate of the same tenor as the certificate referred to in
said Section 6, modified as necessary to relate to the Registration
Statement and the Prospectus as amended and supplemented to the
date of delivery of such certificate.
(l) Bring Down Opinions; Negative
Assurance. At each Representation Date, unless waived by the
Manager, the Company shall furnish or cause to be furnished
forthwith to the Manager and to counsel to the Manager a written
opinion of counsel to the Company (“Company Counsel”) and the
Company’s Washington state counsel addressed to the Manager
and dated and delivered on such Representation Date, in form and
substance reasonably satisfactory to the Manager, including a
negative assurance representation.
23
(m) Auditor Bring Down
“Comfort” Letter. At each Representation Date,
unless waived by the Manager, the Company shall cause (i) the
Accountants, or other independent accountants satisfactory to the
Manager, forthwith to furnish the Manager a letter and (ii) the
Chief Financial Officer of the Company forthwith to furnish the
Manager a certificate, in each case dated on such Representation
Date, in form satisfactory to the Manager, of the same tenor as the
letters and certificate referred to in Section 6 of this Agreement
but modified to relate to the Registration Statement and the
Prospectus, as amended and supplemented to the date of such letters
and certificate; provided, however, that the Company will
not be required to cause the Accountants to furnish such letters to
the Manager in connection with the filing of a Current Report on
Form 8-K unless (A) such Current Report on Form 8-K is filed at any
time during which a prospectus relating to the Shares is required
to be delivered under the Act and (B) the Manager has requested
such letter based upon the event or events reported in such Current
Report on Form 8-K.
(n) Due Diligence Session. Upon
commencement of the offering of the Shares under this Agreement
(and upon the recommencement of the offering of the Shares under
this Agreement following the termination of a suspension of sales
hereunder lasting more than 30 trading days), and at each
Representation Date, the Company will conduct a due diligence
session, in form and substance reasonably satisfactory to the
Manager, which shall include representatives of management and
Accountants. The Company shall cooperate timely with any reasonable
due diligence request from, or review conducted by, the Manager or
its agents, from time to time, in connection with the transactions
contemplated by this Agreement, including, without limitation,
providing information and available documents and access to
appropriate corporate officers and the Company’s agents
during regular business hours and at the Company’s principal
offices, and timely furnishing or causing to be furnished such
certificates, letters and opinions from the Company, its officers
and its agents as the Manager may reasonably request. The Company
shall reimburse the Manager for Manager’s counsel’s
time in each such due diligence update session, up to a maximum of
$7,500 per update, plus any incidental expense incurred by the
Manager in connection therewith.
(o) Acknowledgment of Trading. The
Company consents to the Manager trading in the Common Stock for the
Manager’s own account and for the account of its clients at
the same time as sales of the Shares occur pursuant to this
Agreement or pursuant to a Terms Agreement.
24
(p) Disclosure of Shares Sold. The
Company will disclose in its Annual Reports on Form 10-K and
Quarterly Reports on Form 10-Q, as applicable, the number of Shares
sold through the Manager under this Agreement, the Net Proceeds to
the Company and the compensation paid by the Company with respect
to sales of Shares pursuant to this Agreement during the relevant
quarter, and, if required by any subsequent change in Commission
policy or request, more frequently by means of a Current Report on
Form 8-K or a further Prospectus Supplement.
(q) Rescission Right. If to the
knowledge of the Company, the conditions set forth in Section 6 of
this Agreement shall not have been satisfied as of the applicable
Settlement Date, the Company will offer to any Person who has
agreed to purchase Shares from the Company as the result of an
offer to purchase solicited by the Manager the right to refuse to
purchase and pay for such Shares.
(r) Bring Down of Representations and
Warranties. Each acceptance by the Company of an offer to
purchase the Shares hereunder, and each execution and delivery by
the Company of a Terms Agreement, shall be deemed to be an
affirmation to the Manager that the representations and warranties
of the Company contained in, or made pursuant to, this Agreement
are true and correct as of the date of such acceptance or of such
Terms Agreement as though made at and as of such date, and an
undertaking that such representations and warranties will be true
and correct as of the Settlement Date for the Shares relating to
such acceptance or as of the Time of Delivery relating to such
sale, as the case may be, as though made at and as of such date
(except that such representations and warranties shall be deemed to
relate to the Registration Statement and the Prospectus as amended
and supplemented relating to such Shares).
(s) Reservation of Shares. The
Company shall ensure that there are at all times sufficient shares
of Common Stock to provide for the issuance, free of any preemptive
rights, out of its authorized but unissued shares of Common Stock
or shares of Common Stock held in treasury, of the maximum
aggregate number of Shares authorized for issuance by the Board
pursuant to the terms of this Agreement. The Company will use its
commercially reasonable efforts to cause the Shares to be listed
for trading on the Trading Market and to maintain such
listing.
(t) Obligation under Exchange Act.
During any period when the delivery of a prospectus relating to the
Shares is required (including in circumstances where such
requirement may be satisfied pursuant to Rule 172, Rule 173 or any
similar rule) to be delivered under the Act, the Company will file
all documents required to be filed with the Commission pursuant to
the Exchange Act within the time periods required by the Exchange
Act and the regulations thereunder.
25
(u) DTC Facility. The Company shall
cooperate with the Manager and use its reasonable efforts to permit
the Shares to be eligible for clearance and settlement through the
facilities of the DTC.
(v) Use of Proceeds. The Company
will apply the Net Proceeds from the sale of the Shares in the
manner set forth in the Prospectus.
(w) Filing of Prospectus
Supplement. The Company agrees that on such dates as the Act
shall require, the Company will (i) file a prospectus supplement
with the Commission under the applicable paragraph of Rule 424(b)
under the Act (each and every filing under Rule 424(b), a
“Filing
Date”), which prospectus supplement will set forth,
within the relevant period, the amount of Shares sold through the
Manager, the Net Proceeds to the Company and the compensation
payable by the Company to the Manager with respect to such Shares
(provided that the
Company may satisfy its obligations under this Section 4(w)(i) by
effecting a filing in accordance with the Exchange Act with respect
to such information) and (ii) deliver such number of copies of each
such prospectus supplement or Exchange Act report to each exchange
or market on which such sales were effected as may be required by
the rules or regulations of such exchange or market. In the event
any sales are made pursuant to this Agreement which are NOT made in
“at the market” offerings as defined in Rule 415,
including, without limitation, any Placement pursuant to a Terms
Agreement, the Company shall file a Prospectus Supplement
describing the terms of such transaction, the amount of Shares
sold, the price thereof, the Manager’s compensation, and such
other information as may be required pursuant to Rule 424 and Rule
430B, as applicable, within the time required by Rule
424.
(x) Additional Registration
Statement. To the extent that the Registration Statement is
not available for the sales of the Shares as contemplated by this
Agreement, the Company shall file a new registration statement with
respect to any additional shares of Common Stock necessary to
complete such sales of the Shares and shall cause such registration
statement to become effective as promptly as practicable. After the
effectiveness of any such registration statement, all references to
Registration Statement included in this Agreement shall be deemed
to include such new registration statement, including all documents
incorporated by reference therein pursuant to Item 12 of Form S-3,
and all references to Base Prospectus included in this Agreement
shall be deemed to include the final form of prospectus, including
all documents incorporated therein by reference, included in any
such registration statement at the time such registration statement
became effective.
26
5. Payment of Expenses. The
Company agrees to pay the costs and expenses incident to the
performance of its obligations under this Agreement, whether or not
the transactions contemplated hereby are consummated, including,
without limitation: (i) the preparation, printing or reproduction
and filing with the Commission of the Registration Statement
(including financial statements and exhibits thereto), the
Prospectus and each Issuer Free Writing Prospectus, and each
amendment or supplement to any of them, (ii) the printing (or
reproduction) and delivery (including postage, air freight charges
and charges for counting and packaging) of such copies of the
Registration Statement, the Prospectus, and each Issuer Free
Writing Prospectus, and all amendments or supplements to any of
them, as may, in each case, be reasonably requested for use in
connection with the offering and sale of the Shares, (iii) the
preparation, printing, authentication, issuance and delivery of
certificates for the Shares, including any stamp or transfer taxes
in connection with the original issuance and sale of the Shares,
(iv) the printing (or reproduction) and delivery of this Agreement,
any blue sky memorandum and all other agreements or documents
printed (or reproduced) and delivered in connection with the
offering of the Shares, (v) the registration of the Shares under
the Exchange Act, if applicable, and the listing of the Shares on
the Trading Market, (vi) any registration or qualification of the
Shares for offer and sale under the securities or blue sky laws of
the several states (including filing fees and the reasonable fees
and expenses of counsel for the Manager relating to such
registration and qualification), (vii) the transportation and other
expenses incurred by or on behalf of Company representatives in
connection with presentations to prospective purchasers of the
Shares, (viii) the fees and expenses of the Company’s
Accountants and the fees and expenses of counsel (including local
and special counsel) for the Company, (ix) the filing fee under
FINRA Rule 5110, (x) the reasonable fees and expenses of the
Manager’s counsel, not to exceed $75,000 (excluding any
periodic due diligence fees provided for under Section 4(n)) of
this Agreement and (xi) all other costs and expenses incident to
the performance by the Company of its obligations
hereunder.
6. Conditions to the Obligations of the
Manager. The obligations of the Manager under this Agreement
and any Terms Agreement shall be subject to (i) the accuracy of the
representations and warranties on the part of the Company contained
herein as of the Execution Time, each Representation Date, and as
of each Applicable Time, Settlement Date and Time of Delivery, (ii)
to the performance by the Company of its obligations hereunder and
(iii) the following additional conditions:
(a) Filing of Prospectus
Supplement. The Prospectus, and any supplement thereto,
required by Rule 424 to be filed with the Commission have been
filed in the manner and within the time period required by Rule
424(b) with respect to any sale of Shares; each Prospectus
Supplement shall have been filed in the manner required by Rule
424(b) within the time period required hereunder and under the Act;
any other material required to be filed by the Company pursuant to
Rule 433(d) under the Act, shall have been filed with the
Commission within the applicable time periods prescribed for such
filings by Rule 433; and no stop order suspending the effectiveness
of the Registration Statement or any notice objecting to its use
shall have been issued and no proceedings for that purpose shall
have been instituted or threatened.
27
(b) Delivery of Opinion. The
Company shall have caused the Company Counsel and the
Company’s Washington state counsel to furnish to the Manager,
requested by the Manager and upon reasonable advance notice in
connection with any offering of the Shares, its opinion and
negative assurance statement, dated as of such date and addressed
to the Manager in form and substance acceptable to the
Manager.
(c) Delivery of Officer’s
Certificate. The Company shall have furnished or caused to
be furnished to the Manager, to the extent requested by the Manager
and upon reasonable advance notice in connection with any offering
of the Shares, a certificate of the Company signed by the Chief
Executive Officer or the President and the principal financial or
accounting officer of the Company, dated as of such date, to the
effect that the signers of such certificate have carefully examined
the Registration Statement, the Prospectus, any Prospectus
Supplement and any documents incorporated by reference therein and
any supplements or amendments thereto and this Agreement and
that:
(i) the representations
and warranties of the Company in this Agreement are true and
correct on and as of such date with the same effect as if made on
such date and the Company has complied with all of the agreements
and has satisfied all of the conditions on its part to be performed
or satisfied at or prior to such date;
(ii) no
stop order suspending the effectiveness of the Registration
Statement or any notice objecting to its use has been issued and no
proceedings for that purpose have been instituted or, to the
Company’s knowledge, threatened; and
(iii) since
the date of the most recent financial statements included in the
Registration Statement, the Prospectus and the Incorporated
Documents, there has been no Material Adverse Effect on the
condition (financial or otherwise), earnings, business or
properties of the Company and the Subsidiaries, taken as a whole,
whether or not arising from transactions in the ordinary course of
business, except as set forth in, or contemplated by, the
Registration Statement and the Prospectus.
(d) Delivery of Accountants’
“Comfort” Letter. The Company shall have
requested and caused the Accountants to have furnished to the
Manager, to the extent requested by the Manager and upon reasonable
advance notice in connection with any offering of the Shares,
letters (which may refer to letters previously delivered to the
Manager), dated as of such date, in form and substance satisfactory
to the Manager, confirming that they are independent accountants
within the meaning of the Act and the Exchange Act and the
respective applicable rules and regulations adopted by the
Commission thereunder and that they have performed a review of any
unaudited interim financial information of the Company or
Morinda Holdings, Inc., as
applicable, and included or incorporated by reference in the
Registration Statement and the Prospectus and provide customary
“comfort” as to such review in form and substance
satisfactory to the Manager.
28
(e) No Material Adverse Event.
Since the respective dates as of which information is disclosed in
the Registration Statement, the Prospectus and the Incorporated
Documents, except as otherwise stated therein, there shall not have
been (i) any change or decrease in previously reported results
specified in the letter or letters referred to in paragraph (d) of
this Section 6 or (ii) any change, or any development involving a
prospective change, in or affecting the condition (financial or
otherwise), earnings, business or properties of the Company and the
Subsidiaries, taken as a whole, whether or not arising from
transactions in the ordinary course of business, except as set
forth in, or contemplated by, the Registration Statement, the
Prospectus and the Incorporated Documents (exclusive of any
amendment or supplement thereto) the effect of which, in any case
referred to in clause (i) or (ii) above, is, in the sole judgment
of the Manager, so material and adverse as to make it impractical
or inadvisable to proceed with the offering or delivery of the
Shares as contemplated by the Registration Statement (exclusive of
any amendment thereof), the Incorporated Documents and the
Prospectus (exclusive of any amendment or supplement
thereto).
(f) Payment of All Fees. The
Company shall have paid the required Commission filing fees
relating to the Shares within the time period required by Rule
456(b)(1)(i) of the Act without regard to the proviso therein and
otherwise in accordance with Rule 456(b) and Rule 457(r) of the Act
and, if applicable, shall have updated the “Calculation of
Registration Fee” table in accordance with Rule 456(b)(1)(ii)
of the Act either in a post-effective amendment to the Registration
Statement or on the cover page of a prospectus filed pursuant to
Rule 424(b).
(g) No FINRA Objections. FINRA
shall not have raised any objection with respect to the fairness
and reasonableness of the terms and arrangements under this
Agreement.
(h) Shares Listed on Trading
Market. The Shares shall have been listed and admitted and
authorized for trading on the Trading Market, and satisfactory
evidence of such actions shall have been provided to the
Manager.
(i) Other Assurances. Prior to each
Settlement Date and Time of Delivery, as applicable, the Company
shall have furnished to the Manager such further information,
certificates and documents as the Manager may reasonably
request.
If any
of the conditions specified in this Section 6 shall not have been
fulfilled when and as provided in this Agreement, or if any of the
opinions and certificates mentioned above or elsewhere in this
Agreement shall not be reasonably satisfactory in form and
substance to the Manager and counsel for the Manager, this
Agreement and all obligations of the Manager hereunder may be
canceled at, or at any time prior to, any Settlement Date or Time
of Delivery, as applicable, by the Manager. Notice of such
cancellation shall be given to the Company in writing, or by
telephone or facsimile and confirmed in writing.
29
The
documents required to be delivered by this Section 6 shall be
delivered at the office of Xxxxxxxxxx Xxxxxxx LLP, counsel for the
Manager, at 0000 Xxxxxx xx xxx Xxxxxxxx, Xxx Xxxx, Xxx Xxxx 00000,
on each such date as provided in this Agreement.
7. Indemnification and
Contribution.
(a) Indemnification by Company. The
Company agrees to indemnify and hold harmless the Manager, the
directors, officers, employees and agents of the Manager and each
Person who controls the Manager within the meaning of either the
Act or the Exchange Act against any and all losses, claims, damages
or liabilities, joint or several, to which they or any of them may
become subject under the Act, the Exchange Act or other federal or
state statutory law or regulation, at common law or otherwise,
insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon any untrue
statement or alleged untrue statement of a material fact contained
in the Registration Statement for the registration of the Shares as
originally filed or in any amendment thereof, or in the Base
Prospectus, any Prospectus Supplement, the Prospectus, any Issuer
Free Writing Prospectus, the Incorporated Documents or in any
amendment thereof or supplement thereto, or arise out of, or are
based upon, the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make
the statements therein not misleading, or result from or relate to
any breach of any of the representations, warranties, covenants or
agreements made by the Company in this Agreement, and agrees to
reimburse each such indemnified party for any legal or other
expenses reasonably incurred by them in connection with
investigating or defending any such loss, claim, damage, liability
or action; provided, however, that the Company will
not be liable in any such case to the extent that any such loss,
claim, damage or liability arises out of or is based upon any such
untrue statement or alleged untrue statement or omission or alleged
omission made therein in reliance upon and in conformity with
written information furnished to the Company by the Manager
specifically for inclusion therein. This indemnity provision will
be in addition to any liability that the Company may otherwise
have.
(b) Indemnification by Manager. The
Manager agrees to indemnify and hold harmless the Company, each of
its directors, each of its officers who signs the Registration
Statement, and each Person who controls the Company within the
meaning of either the Act or the Exchange Act, to the same extent
as the foregoing indemnity from the Company to the Manager, but
only with reference to written information relating to the Manager
furnished to the Company by the Manager specifically for inclusion
in the documents referred to in the foregoing indemnity;
provided,
however, that in no
case shall the Manager be responsible for any amount in excess of
the Broker Fee applicable to the Shares and paid hereunder. This
indemnity provision will be in addition to any liability which the
Manager may otherwise have.
30
(c) Indemnification Procedures.
Promptly after receipt by an indemnified party under this Section 7
of notice of the commencement of any action, such indemnified party
will, if a claim in respect thereof is to be made against the
indemnifying party under this Section 7, notify the indemnifying
party in writing of the commencement thereof but the failure so to
notify the indemnifying party (i) will not relieve it from
liability under paragraph (a) or (b) above unless and to the extent
it did not otherwise learn of such action and such failure results
in the forfeiture by the indemnifying party of substantial rights
and defenses and (ii) will not, in any event, relieve the
indemnifying party from any obligations to any indemnified party
other than the indemnification obligation provided in paragraph (a)
or (b) above. The indemnifying party shall be entitled to appoint
counsel of the indemnifying party’s choice at the
indemnifying party’s expense to represent the indemnified
party in any action for which indemnification is sought (in which
case the indemnifying party shall not thereafter be responsible for
the fees and expenses of any separate counsel retained by the
indemnified party or parties except as set forth below);
provided,
however, that such
counsel shall be reasonably satisfactory to the indemnified party.
Notwithstanding the indemnifying party’s election to appoint
counsel to represent the indemnified party in an action, the
indemnified party shall have the right to employ separate counsel
(including local counsel), and the indemnifying party shall bear
the reasonable fees, costs and expenses of such separate counsel if
(i) the use of counsel chosen by the indemnifying party to
represent the indemnified party would present such counsel with a
conflict of interest, (ii) the actual or potential defendants in,
or targets of, any such action include both the indemnified party
and the indemnifying party and the indemnified party shall have
reasonably concluded that there may be legal defenses available to
it and/or other indemnified parties which are different from or
additional to those available to the indemnifying party, (iii) the
indemnifying party shall not have employed counsel reasonably
satisfactory to the indemnified party to represent the indemnified
party within a reasonable time after notice of the institution of
such action or (iv) the indemnifying party shall authorize the
indemnified party to employ separate counsel at the expense of the
indemnifying party. An indemnifying party will not, without the
prior written consent of the indemnified parties, settle or
compromise or consent to the entry of any judgment with respect to
any pending or threatened claim, action, suit or proceeding in
respect of which indemnification or contribution may be sought
hereunder (whether or not the indemnified parties are actual or
potential parties to such claim or action) unless such settlement,
compromise or consent includes an unconditional release of each
indemnified party from all liability arising out of such claim,
action, suit or proceeding.
31
(d) Contribution. In the event that
the indemnity provided in paragraph (a), (b) or (c) of this Section
7 is unavailable or insufficient to hold harmless an indemnified
party for any reason, the Company and the Manager agree to
contribute to the aggregate losses, claims, damages and liabilities
(including legal or other expenses reasonably incurred in
connection with investigating or defending the same) (collectively,
“Losses”) to which the
Company and the Manager may be subject in such proportion as is
appropriate to reflect the relative benefits received by the
Company, on the one hand, and by the Manager, on the other, from
the offering of the Shares; provided, however, that in no case shall
the Manager be responsible for any amount in excess of the Broker
Fee applicable to the Shares and paid hereunder. If the allocation
provided by the immediately preceding sentence is unavailable for
any reason, the Company and the Manager severally shall contribute
in such proportion as is appropriate to reflect not only such
relative benefits but also the relative fault of the Company, on
the one hand, and of the Manager, on the other, in connection with
the statements or omissions which resulted in such Losses as well
as any other relevant equitable considerations. Benefits received
by the Company shall be deemed to be equal to the total net
proceeds from the offering (before deducting expenses) received by
it, and benefits received by the Manager shall be deemed to be
equal to the Broker Fee applicable to the Shares and paid hereunder
as determined by this Agreement. Relative fault shall be determined
by reference to, among other things, whether any untrue or any
alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information
provided by the Company, on the one hand, or the Manager, on the
other, the intent of the parties and their relative knowledge,
access to information and opportunity to correct or prevent such
untrue statement or omission. The Company and the Manager agree
that it would not be just and equitable if contribution were
determined by pro rata allocation or any other method of allocation
which does not take account of the equitable considerations
referred to above. Notwithstanding the provisions of this paragraph
(d), no Person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Act) shall be entitled to
contribution from any Person who was not guilty of such fraudulent
misrepresentation. For purposes of this Section 7, each Person who
controls the Manager within the meaning of either the Act or the
Exchange Act and each director, officer, employee and agent of the
Manager shall have the same rights to contribution as the Manager,
and each Person who controls the Company within the meaning of
either the Act or the Exchange Act, each officer of the Company who
shall have signed the Registration Statement and each director of
the Company shall have the same rights to contribution as the
Company, subject in each case to the applicable terms and
conditions of this paragraph (d).
32
8. Termination.
(a) The Company shall
have the right, by giving written notice as hereinafter specified,
to terminate the provisions of this Agreement relating to the
solicitation of offers to purchase the Shares in its sole
discretion at any time upon five (5) Business Days’ prior
written notice. Any such termination shall be without liability of
any party to any other party except that (i) with respect to any
pending sale through the Manager for the Company, the obligations
of the Company, including in respect of compensation of the
Manager, shall remain in full force and effect notwithstanding the
termination and (ii) the provisions of Sections 5, 6, 7, 8, 9, 10,
12 and 14 of this Agreement shall remain in full force and effect
notwithstanding such termination.
(b) The Manager shall
have the right, by giving written notice as hereinafter specified,
to terminate the provisions of this Agreement relating to the
solicitation of offers to purchase the Shares in its sole
discretion at any time. Any such termination shall be without
liability of any party to any other party except that the
provisions of Sections 5, 6, 7, 8, 9, 10, 12 and 14 of this
Agreement shall remain in full force and effect notwithstanding
such termination.
(c) This Agreement
shall remain in full force and effect until the earlier of April
30, 2020 and such date that this Agreement is terminated pursuant
to Sections 8(a) or (b) above or otherwise by mutual agreement of
the parties; provided that any such
termination by mutual agreement shall in all cases be deemed to
provide that Sections 5, 6, 7, 8, 9, 10, 12 and 14 shall remain in
full force and effect.
(d) Any termination of
this Agreement shall be effective on the date specified in such
notice of termination; provided that such termination
shall not be effective until the close of business on the date of
receipt of such notice by the Manager or the Company, as the case
may be. If such termination shall occur prior to the Settlement
Date or Time of Delivery for any sale of the Shares, such sale
shall settle in accordance with the provisions of Section 2(b) of
this Agreement.
(e) In the case of any
purchase of Shares by the Manager pursuant to a Terms Agreement,
the obligations of the Manager pursuant to such Terms Agreement
shall be subject to termination, in the absolute discretion of the
Manager, by prompt oral notice given to the Company prior to the
Time of Delivery relating to such Shares, if any, and confirmed
promptly by facsimile or electronic mail, if since the time of
execution of the Terms Agreement and prior to such delivery and
payment, (i) trading in the Company’s Common Stock shall have
been suspended by the Commission or the Trading Market or trading
in securities generally on the Trading Market shall have been
suspended or limited or minimum prices shall have been established
on such exchange, (ii) a banking moratorium shall have been
declared either by Federal or New York State authorities or (iii)
there shall have occurred any outbreak or escalation of
hostilities, declaration by the United States of a national
emergency or war, or other calamity or crisis the effect of which
on financial markets is such as to make it, in the sole judgment of
the Manager, impractical or inadvisable to proceed with the
offering or delivery of the Shares as contemplated by the
Prospectus (exclusive of any amendment or supplement
thereto).
33
9. Representations and Indemnities to
Survive. The respective agreements, representations,
warranties, indemnities and other statements of the Company or its
officers and of the Manager set forth in or made pursuant to this
Agreement will remain in full force and effect, regardless of any
investigation made by the Manager or the Company or any of the
officers, directors, employees, agents or controlling persons
referred to in Section 7, and will survive delivery of and payment
for the Shares.
10. Notices. All communications
hereunder will be in writing and effective only on receipt, and, if
sent to the Manager, will be mailed, delivered or facsimiled to the
address set forth on the signature page hereto.
11. Successors. This Agreement will
inure to the benefit of, and be binding upon, the parties hereto
and their respective successors and the officers, directors,
employees, agents and controlling persons referred to in Section 7,
and no other Person will have any right or obligation
hereunder.
12. No Fiduciary Duty. The Company
hereby acknowledges that (i) the purchase and sale of the Shares
pursuant to this Agreement is an arm’s-length commercial
transaction between the Company, on the one hand, and the Manager
and any affiliate through which it may be acting, on the other,
(ii) the Manager is acting solely as sales agent and/or principal
in connection with the purchase and sale of the Company’s
securities and not as a fiduciary of the Company and (iii) the
Company’s engagement of the Manager in connection with the
offering and the process leading up to the offering is as an
independent contractor and not in any other capacity. Furthermore,
the Company agrees that it is solely responsible for making its own
judgments in connection with the offering (irrespective of whether
the Manager has advised or is currently advising the Company on
related or other matters). The Company agrees that it will not
claim that the Manager has rendered advisory services of any nature
or respect, or owes an agency, fiduciary or similar duty to the
Company, in connection with such transaction or the process leading
thereto.
13. Integration. This Agreement and
any Terms Agreement supersede all prior agreements and
understandings (whether written or oral) between the Company and
the Manager with respect to the subject matter hereof.
14. Applicable Law. This Agreement
and any Terms Agreement will be governed by and construed in
accordance with the laws of the State of New York applicable to
contracts made and to be performed within the State of New
York.
15. WAIVER
OF JURY TRIAL. THE COMPANY HEREBY IRREVOCABLY WAIVES, TO THE
FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO
TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO
THIS AGREEMENT, ANY TERMS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY OR THEREBY.
34
16. Counterparts. This Agreement
and any Terms Agreement may be signed in one or more counterparts,
each of which shall constitute an original and all of which
together shall constitute one and the same agreement, which may be
delivered by facsimile or in .pdf file via e-mail.
17. Headings. The section headings
used in this Agreement and any Terms Agreement are for convenience
only and shall not affect the construction hereof.
***************************
35
If the
foregoing is in accordance with your understanding of our
agreement, please sign and return to us the enclosed duplicate
hereof, whereupon this Agreement and your acceptance shall
represent a binding agreement among the Company and the
Manager.
Very
truly yours,
NEW
AGE BEVERAGES CORPORATION
By:
/s/ Xxxxxxx X. Xxxxx
Name:
Xxxxxxx X. Xxxxx
Title:
Chief Financial Officer
Address
for Notice:
The
foregoing Agreement is hereby confirmed and accepted as of the date
first written above.
XXXX
CAPITAL PARTNERS, LLC
By:
/s/ Xxxxx X. Xxxxxxxx
Name:
Xxxxx X.
Xxxxxxxx
Title:
Head of
Equity Capital Markets
Address
for Notice:
ANNEX I
FORM OF TERMS AGREEMENT
NEW AGE BEVERAGES CORPORATION TERMS AGREEMENT
Dear
Sirs:
New Age
Beverages Corporation (the “Company”) proposes,
subject to the terms and conditions stated herein and in the At The
Market Offering Agreement, dated April 30, 2019 (the
“At The Market
Offering Agreement”), between the Company and Xxxx
Capital Partners, LLC (the “Agent”), to issue and
sell to the Agent the securities specified in Schedule I hereto (the
“Purchased
Shares”).
Each of
the provisions of the At The Market Offering Agreement not
specifically related to the solicitation by Xxxx Capital Partners,
LLC, as agent of the Company, of offers to purchase securities is
incorporated herein by reference in its entirety, and shall be
deemed to be part of this Terms Agreement to the same extent as if
such provisions had been set forth in full herein. Each of the
representations and warranties set forth therein shall be deemed to
have been made at and as of the date of this Terms Agreement and
the Time of Delivery, except that each representation and warranty
in Section 3 of the At The Market Offering Agreement which makes
reference to the Prospectus (as therein defined) shall be deemed to
be a representation and warranty as of the date of the At The
Market Offering Agreement in relation to the Prospectus, and also a
representation and warranty as of the date of this Terms Agreement
and the Time of Delivery in relation to the Prospectus, as amended
and supplemented, to relate to the Purchased Shares.
An
amendment to the Registration Statement (as defined in the At The
Market Offering Agreement), or a supplement to the Prospectus, as
the case may be, relating to the Purchased Shares, in the form
heretofore delivered to the Agent, is now proposed to be filed with
the Securities and Exchange Commission.
Subject
to the terms and conditions set forth herein and in the At The
Market Offering Agreement, which are incorporated herein by
reference, the Company agrees to issue and sell to the Agent and
the latter agrees to purchase from the Company the number of shares
of the Purchased Shares at the time and place and at the purchase
price set forth in Schedule I hereto.
ANNEX
I
If the
foregoing is in accordance with your understanding, please sign and
return to us a counterpart hereof, whereupon this Terms Agreement,
including those provisions of the At The Market Offering Agreement
incorporated herein by reference, shall constitute a binding
agreement between the Manager and the Company.
NEW
AGE BEVERAGES CORPORATION
By:
/s/ Xxxxxxx X. Xxxxx
Name:
Xxxxxxx X. Xxxxx
Title:
Chief Financial Officer
Accepted as of the
date first written above.
XXXX
CAPITAL PARTNERS, LLC
By:
/s/ Xxxxx X. Xxxxxxxx
Name:
Xxxxx X.
Xxxxxxxx
Title:
Head of
Equity Capital Markets
ANNEX
I
Schedule I
Purchased
Shares
ANNEX
I